FOLH1 and prostate carcinoma: In conclusion, [225Ac]Ac-PSMA-617 effectively treated micrometer or millimeter sized lesions, while [177Lu]Lu-PSMA-617 was only effective for treating millimeter size tumours in preclinical mouse models of prostate cancer.